drugset / Trial / NCT03250494

Duloxetine and Dexamethasone for Improving Postoperative Pain

NCT03250494

Phase 4 Completed 75 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindPrevention

Summary

75 female patients were randomly allocated into one of three equal groups. Group I(GI) received Dulox 60 mg orally and 100 ml 0.9% sodium chloride solution (NS) intravenous infusion (IVI) over 15 min, group II(GII): received combined Dulox capsule 60 mg orally and Dex 0.1mg/kg mixed with 100 ml NS IVI and group III(GIII) received identical placebo duloxetine capsule and 100 ml NS IVI as a placebo for Dex, 2 hours preoperatively. Patients' vitals, VAS and sedation score were assessed at 30 minutes, 1h, 2 h, 6h and 12h postoperatively. Total pethidine requirements, plasma cortisol, PONV and patient's satisfaction were recorded.

Timeline

Start
2014-12
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 0.1 mg/kg Intravenous
Comparator Duloxetine Small molecule 60 mg Oral

Indications

No indication recorded.